Educational Videos
   
Providing continued educational support on topics that matter
to acute health care providers on critically ill AKI patients.
 
Educational Videos
   
Providing continued educational support on topics that matter
to acute health care providers on critically ill AKI patients.
  CRRT in the Era of Drug Shortages  
 
Discussion Overview:

Stephanie Chamberland, RN explains the differences in compounded bags versus commercially available premixed solutions and what can be done to avoid the issues related to drug shortages.

Download presentation Download PDF 2MB

 
THERAPY EDUCATION
 

Phosphate: The Forgotten Electrolyte:
The kidneys' most important function is the regulation of electrolytes, one of which is phosphorous. Greater than 60% of patients will present with hyperphosphatemia with acute renal failure. Pam Waters discusses how you can help critically ill patients with CRRT therapy.

Download presentation Download PDF 914KB

CRRT: Pre and Post Replacement Solutions - A Guide to Understanding:
Pam Waters, RN, explains the uses and benefits of CRRT replacement solutions, and the differences between pre- and post- replacement solutions.

Download presentation Download PDF 3MB

Managing Patient Temperature During CRRT

Managing Patient Temperature During CRRT
Tena Griffin, DNP, CRNP discusses managing patient blood return temperature including current study data and Baxter's recommendations

Download presentation Download PDF 3MB

TMP and Filter Pressure Drop

TMP and Filter Pressure Drop
Kathy Worthington, MSN, RN discusses factors affecting circuit life, CRRT hemodynamics and troubleshooting tips. 

Download presentation Download PDF 1623KB

 
PRODUCT EDUCATION
 

The Future of the PRISMAFLEX System:
Alan Wetsel, Portfolio Manager, Baxter Healthcare Corporation, explains the changes made to the 7.11 software for the Baxter PRISMAFLEX system. He also demonstrates the changes on the actual machine screen.

TRUEVUE Analytics: An overview of Data-driven CRRT
Michael Olesen, RN, walks through an example report and explains how TRUEVUE Analytics (formerly SHARESOURE CONNECT) gives you a powerful tool to better analyze your CRRT data, set benchmarks and optimize patient treatment.

Download presentation Download PDF 2MB

TRUEVUE Analytics: Data-Driven CRRT:
This briefly overviews the types of reporting and trends that can be measured through the TRUEVUE Analytics Software.
CRRT in the Era of Drug Shortages

CRRT in the Era of Drug Shortages
Stephanie Chamberland, RN explains the differences in compounded bags versus commercially available premixed solutions and what can be done to avoid the issues related to drug shortages

Download presentation Download PDF 2MB

 
Audio Podcast Interviews
Medications and RRT: We Know How to Dose, Right?
Pharmacist and Professor Bruce Mueller discusses the difficulties of dosing patients with acute kidney injury and understanding how renal replacement can affect your antibiotics dosing.
 
Achieving Fluid Balance
Kyle Enfield, MD, speaks with Colin K. Grissom, MD, FCCM, and Matthew W. Semler, MD, about fluid management in the critically ill, including the history of fluid management in these patients and how recent study findings are shaping future care.
 
Treating Volume Overload in the ICU with RRT
Rajit Basu, MD, MS, FCCM discusses treating volume overload in the intensive care unit with renal replacement therapy.
 
When to Start Renal Replacement Therapy in Critically Ill Patients: Early versus Late
Michael Connor, MD discusses updates on diagnostic and treatment options in critical illness.
 
Organ Repair and Critical Illness
Organ Repair and Critical Illness
Dr. Pandharipande discusses the impact of critical illness on renal, neurocognitive, neuroendocrine, immune, and physical functions
 
 
 
 
 
The PRISMAFLEX Control Unit is intended for:
Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
Rx Only. For safe and proper use of products mentioned herein refer to the appropriate Instructions for Use or Operator's Manual.

PHOXILLUM Renal Replacement Solution Indications and Important Risk Information

Indications
PHOXILLUM solution is indicated in pediatric and adult patients for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances. It may also be used in case of drug poisoning when CRRT is used to remove dialyzable substances.

Important Risk Information
PHOXILLUM solution can affect electrolytes and volume and may result in hyperkalemia or hyperphosphatemia. Monitor hemodynamic status and fluid inputs and outputs, potassium, phosphorous, calcium, other electrolytes and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately. PHOXILLUM replacement solutions contain hydrogen phosphate, a weak acid that may increase the risk of metabolic acidosis. PHOXILLUM solution can effect blood glucose levels resulting in hypo- or hyper-glycemia depending upon the dextrose content of the replacement solution. Monitor blood glucose levels regularly. Patients may require initiation of or modification of antidiabetic therapy or other corrective measures during treatment.

PRISMASOL Renal Replacement Solution

Indications
PRISMASOL Renal Replacement Solution is indicated in pediatric and adult patients for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolytes and acid-base imbalances. PRISMASOL Solution may also be used in case of drug poisoning when CRRT is used to remove dialyzable substances.

Important Risk Information
PRISMASOL Renal Replacement Solution is contraindicated in patients with known hypersensitivities to this product.
PRISMASOL Solution can affect electrolytes and volume and may result in hyperkalemia or   hyperphosphatemia. Monitor hemodynamic status and fluid inputs and outputs, potassium, phosphorous, other electrolytes and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately. The use of PRISMASOL Solutions containing dextrose can affect blood glucose levels resulting in hypo- or hyper-glycemia depending upon the dextrose content of the replacement solution. Patients may require initiation of or modification of antidiabetic therapy or other corrective measures during treatment.
 
Please see PHOXILLUM and PRISMASOL Solutions full Prescribing Information.